01—Abstract
Summary
Summary of the 8-K filed July 22, 2025. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation (NYSE: THC) reported second quarter 2025 results on July 22, 2025, per Exhibit 99.1, a press release that also raised its 2025 financial outlook.
Net income available to Tenet common shareholders was $288 milliona, or $3.14 per diluted share, versus $259 million, or $2.64 per diluted share, in the second quarter of 2024. Adjusted diluted earnings per share rose to $4.02 from $2.31, and Adjusted EBITDA increased to $1.121 billion from $945 million, with a 21.3% Adjusted EBITDA margin. Net operating revenues were $5.271 billion, up from $5.108 billion.
Results were supported by same-facility revenue growth, higher acuity, favorable payer mix and disciplined expense management. The Hospital segment recognized a $79 millionb favorable pre-tax impact from additional Medicaid supplemental revenues related to prior periods, including a recently approved program in Tennessee, compared with a $30 million benefit in the second quarter of 2024. Ambulatory Care net operating revenues were $1.270 billion, and same-facility system-wide net patient service revenues rose 7.7%.
Cash generation and capital returns were strong. Six-month free cash flow was $1.385 billionc, and the Board authorized a $1.5 billion increase to the share repurchase program, leaving $1.781 billion available as of July 22, 2025.
The net debt to Adjusted EBITDA ratio was 2.45x at June 30, 2025. Full-year 2025 Adjusted EBITDA is now expected between $4.40 billiond and $4.54 billion, a $395 million increase at the midpoint.
02—Key points
Key Highlights
- Q2 2025 net income available to common shareholders was $288 million, or $3.14 per diluted share, up from $259 million, or $2.64 per diluted share, in Q2 2024.
- Adjusted diluted EPS was $4.02 in Q2 2025 versus $2.31 in Q2 2024; Adjusted EBITDA was $1.121 billion versus $945 million, at a 21.3% margin.
- Hospital segment Q2 2025 included a $79 million favorable pre-tax impact from prior-period Medicaid supplemental revenues, including a recently approved Tennessee program.
- Free cash flow was $1.385 billion for the six months ended June 30, 2025, versus $948 million a year earlier.
- The Board authorized a $1.5 billion increase to the share repurchase program, with $1.781 billion remaining as of July 22, 2025; the company repurchased $747 million of stock in Q2 2025.
- Net debt to Adjusted EBITDA was 2.45x at June 30, 2025, compared with 2.54x at December 31, 2024.
- FY 2025 outlook was raised: Adjusted EBITDA is now expected at $4.40 billion to $4.54 billion, and Adjusted diluted EPS at $15.55 to $16.21.
03—Questions
Frequently Asked Questions
How did Tenet perform in the second quarter of 2025?
Net operating revenues rose to $5.271 billion from $5.108 billion. Net income available to common shareholders was $288 million, or $3.14 per diluted share, compared with $259 million, or $2.64 per diluted share, a year earlier. Adjusted EBITDA reached $1.121 billion, up from $945 million.
What drove the improvement in Adjusted EBITDA?
The company cited strong same-facility revenue growth, higher acuity, favorable payer mix and disciplined expense management. The Hospital segment also recognized a $79 million favorable pre-tax impact from additional Medicaid supplemental revenues related to prior periods.
What changed in Tenet's full-year 2025 outlook?
Full-year 2025 Adjusted EBITDA is now expected to be between $4.40 billion and $4.54 billion, a $395 million increase at the midpoint. The outlook also projects net operating revenues of $20.950 billion to $21.250 billion and free cash flow of $2.025 billion to $2.275 billion.
How is Tenet returning capital to shareholders?
The Board authorized a $1.5 billion increase to the share repurchase program, leaving $1.781 billion available as of July 22, 2025. In the first half of 2025, Tenet repurchased 7.2 million shares for $1.095 billion, including 4.6 million shares for $747 million in the second quarter.
How leveraged is Tenet's balance sheet?
The ratio of net debt to Adjusted EBITDA was 2.45x at June 30, 2025, down from 2.46x at March 31, 2025 and 2.54x at December 31, 2024. Cash and cash equivalents were $2.625 billion at June 30, 2025.
04—Continue